Carl Bilbo

Carl Bilbo is an accomplished professional with extensive experience in leadership roles within the pharmaceutical and biotechnology sectors. Currently serving as Chairperson of the Board at Hedia since June 2024, Carl has also held significant positions such as Board Member at Supersapiens and Senior Vice President, Microbiome Franchise at Ferring Pharmaceuticals. Prior to this, Carl spent over two decades at Novo Nordisk in various senior roles, including Corporate Vice President for Commercial Affairs and Strategy, and leadership in marketing operations across multiple therapeutic areas. With a strong educational background that includes a PhD in Biostatistics from the Technical University of Denmark and executive programs from prestigious institutions like Harvard Business School and INSEAD, Carl combines strategic acumen with scientific expertise to drive innovation and commercial success.